Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
47 Мб
Скачать
Div
34 Composite Pelvic Resection forOvarian Cancer
Fig. 34.2 Fecal diversion for post­operative anastomotic leak
erting loop
Ileostomy
383
contrast should be performed prior to ostomy reversal to ensure no persistent leaks or stric­tures. Reversal is usually performed about 12weeks after the initial injury if adequate nutri­tion and performance status have been re-established.
In some cases, intra-abdominal adhesions or a “frozen abdomen” render the usual diversion and/or repair impossible. Damage control meth­ods including temporary abdominal closure, open abdomen negative pressure therapy, or delayed abdominal closure may be necessary. Collaboration with a colorectal or trauma sur­geon is often helpful in these cases.

Bowel Injury

Background

Bowel injury can occur during composite pelvic resection when the colon or small bowel is adher-
Anastomotic leak
ent to or invaded by a bulky pelvic mass or when the serosa or mesentery is involved by miliary disease.

Prevention

Prevention of bowel injury begins with careful tissue handling and sharp rather than cautery or blunt dissection in proximity to the bowel wall. Thermal injuries are especially danger­ous since the initial injury may be unrecog­nized, or its extent minimized, and thus present several days to a week post-operatively. A rec­tal probe or proctoscopy with insufflation to distend the colon during dissection can better delineate the bowel wall. Inspection of the entire large and small bowel should be per­formed in order to identify and repair any inju­ries prior to closure. A systematic approach to examining the bowel can avoid unrecognized injuries.
384
B. Long and W. A. Cliby

Recognition

Careful inspection of both the small and large bowel should be performed to rule out inadver­tent serosal injuries, colotomies or enterotomies, or thermal injuries. While anastomotic leaks are most feared, it is important to remember that enteric leaks in the absence of bowel resection are a common source of major post-operative morbidity. Proctoscopy to distend the pelvic colon with air can also be useful to recognize occult injuries.
A delayed or unrecognized bowel injury will present similarly to an anastomotic leak, as described above (“Anastomotic leak: recognition”).

Management

When bowel injury is noted intra-operatively, pri­mary repair can be performed for small defects. The bowel is typically repaired in two layers, using a running, delayed absorbable suture to reapproximate the mucosa and permanent (silk) Lambert sutures to reapproximate the serosa. The defect should be repaired in a transverse fashion in order to prevent the narrowing of the bowel lumen. Larger defects, thermal injuries or those involving the mesentery of the small or large bowel typically require resection of the damaged segment. Primary anastomosis can be performed in most cases.
Delayed bowel injuries are managed similarly to anastomotic leaks, as described above (‘Anastomotic leak: Recognition’).

Prevention

There are no well-established methods for the prevention of anastomotic bleeding. Intra­operative proctoscopy can be used to ensure hemostasis at the anastomosis, but most bleeding is delayed. There is no high-quality evidence to suggest a lower risk of bleeding with hand-sewn or stapled anastomoses.

Recognition

Anastomotic bleeding presents as hematochezia or passage of blood and clots per rectum. This usually occurs within 24–48 hours post­operatively. Given the distal location of the recto­sigmoid anastomosis, the bleeding is typically immediately apparent.

Management

Bleeding from the rectosigmoid anastomosis fol­lowing composite pelvic resection for ovarian cancer can typically be managed expectantly. Some patients may require transfusion, and anti­coagulation should be held until hemostasis is ensured. If bleeding continues despite conserva­tive measures, colonoscopic clipping or fulgura­tion should be attempted. Re-operation and revision of the anastomosis is rarely required but can be necessary if endoscopic methods are not successful.

Anastomotic Stricture

Anastomotic Bleeding

Background

Anastomotic bleeding (often mucosal) after low anterior resection is rare but can result in signi­cant blood loss and/or contribute to failure of the anastomosis.

Background

Anastomotic stricture is typically attributed to tissue ischemia, though the rate of stricture after composite pelvic resection for ovarian cancer is not well-dened. Risk factors for anastomotic stricture include obesity, anastomotic leak, smok­ing, and low or ultra-low anastomosis.
34 Composite Pelvic Resection forOvarian Cancer
385

Prevention

Anastomotic stricture can result from isch­emia, tension, or subclinical leaks/tissue remodeling. In addition to the maneuvers described above (see: “Anastomotic leak: pre­vention”), surgeons should avoid using circular staplers less than 25mm in diameter: in cases of narrow diameter proximal colon stump an end-to-side anastomosis should be used to avoid this.

Recognition

Anastomotic strictures typically present weeks to months after surgery and should be recognized on imaging when patients present with obstruc­tive symptoms, pain, and/or incontinence.

Management

Anastomotic stricture after rectosigmoid resec­tion typically presents weeks to months after surgery with symptoms of complete or partial obstruction. Low anastomotic strictures can be dilated digitally or with exible dilators. More proximal strictures can be dilated with endo­scopic balloon dilation or stenting. Re-operation for revision of an anastomosis is required in rare cases, and permanent diversion can be per­formed if symptoms persist and revision is not possible.

References

1. Hammond IG, et al. The control of severe intraop­erative bleeding using an overlay autogenous tis­sue (OAT) patch: case reports. Gynecol Oncol. 2004;94(2):564–6.
2. American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice. Topical hemo­static agents at time of obstetric and gynecologic sur­gery: ACOG committee opinion, number 812. Obstet Gynecol. 2020;136(4):e81–9.
3. White LA, Joseph JP, Yang DY, Kelley SR, Mathis KL, Behm K, Viers BR. Intraureteral indocyanine green augments ureteral identication and avoidance during complex robotic-assisted colorectal surgery. Color Dis. 2021;23(3):718–23.
4. Boyan WP Jr, Lavy D, Dinallo A, Otero J, Roding A, Hanos D, Dressner R, Arvanitis M.Lighted ureteral stents in laparoscopic colorectal surgery; a ve-year experience. Ann Transl Med. 2017;5(3):44.
5. Abu-Zaid A, Abou Al-Shaar H, Azzam A, Alomar O, Al-Otaibi MF, Amin T, Al-Badawi IA. Routine ureteric stenting before cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in man­aging peritoneal carcinomatosis from gynecologic malignancies: a single-center experience. Ir J Med Sci. 2017;186(2):269–73.
6. Teeluckdharry B, etal. Urinary tract injury at benign gynecologic surgery and the role of cystoscopy: a sys­tematic review and meta-analysis. Obstet Gynecol. 2015;126(6):1161.
7. Narasimhulu DM, Bews KA, Hanson KT, Chang YH, Dowdy SC, Cliby WA. Using evidence to direct quality improvement efforts: dening the highest impact complications after complex cytore­ductive surgery for ovarian cancer. Gynecol Oncol. 2020;156(2):278–83.
8. Richardson DL, Mariani A, Cliby WA.Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103(2):667–72.
9. Kalogera E, Nitschmann CC, Dowdy SC, Cliby WA, Langstraat CL. A prospective algorithm to reduce anastomotic leaks after rectosigmoid resec­tion for gynecologic malignancies. Gynecol Oncol. 2017;144(2):343–7.
10. Liu D, Liang L, Liu L, Zhu Z. Does intraoperative indocyanine green uorescence angiography decrease the incidence of anastomotic leakage in colorectal surgery? A systematic review and meta-analysis. Int J Color Dis. 2021;36(1):57–66.
11. Pang HY, Chen XL, Song XH, Galiullin D, Zhao LY, Liu K, Zhang WH, Yang K, Chen XZ, Hu JK.Indocyanine green uorescence angiography pre­vents anastomotic leakage in rectal cancer surgery: a systematic review and meta-analysis. Langenbeck’s Arch Surg. 2021;406(2):261–71.
12. De Nardi P, Elmore U, Maggi G, Maggiore R, Boni L, Cassinotti E, Fumagalli U, Gardani M, De Pascale S, Parise P, Vignali A, Rosati R.Intraoperative angi­ography with indocyanine green to assess anasto­mosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter random­ized controlled trial. Surg Endosc. 2020;34(1):53–60.
13. Phitayakorn R, Delaney CP, Reynolds HL, et al. Standardized algorithms for management of anastomotic leaks and related abdominal and pel­vic abscesses after colorectal surgery. World J Surg. 2008;32:1147–56.

Anal Cancer

AnneMacleod andSusanGalandiuk
35

Introduction

First described in 1974, the Nigro protocol using denitive chemoradiotherapy (CRT) is the pri­mary treatment for most cases of anal squamous cell carcinoma (SCC), which encompasses >90% of anal cancers [1, 2]. Surgery is indicated for the treatment of (i) perianal cancers without sphinc­ter involvement (local excision), (ii) patients with persistent or recurrent disease following initial chemoradiation therapy (salvage surgery), (iii) complications of primary disease, and (iv) com­plications resulting from chemoradiation therapy (CRT).
This chapter will focus primarily on the man­agement of complications of radical surgery per­formed for progressive disease including, (i) perineal wound complications; (ii) pelvic uid collections/abscess/organ space infection; (iii) perineal hernia, and (iv) small bowel obstruction as well as those secondary to primary disease and
chemoradiation therapy. Complications of pri­mary disease and nonoperative therapy discussed include large bowel obstruction; fecal inconti­nence; rectovaginal and anorectal stulae; sig­moid and ureteral stricture formation and radiation enteritis.
Complications ofLocal Excision
Local excision for anal squamous cell cancer is indicated in T1N0, well-differentiated peri-anal cancer [3, 4] as well as supercial anal cancer that has been completely excised (T1NX <3mm deep and <7mm horizontal spread) (Fig.35.1). These are often completely excised at biopsy, and local resection with negative margins may be suf­cient [3, 5] (Fig.35.2). Complications of local excision are uncommon; if healing problems occur, most wounds will heal by secondary intention.
A. Macleod Price Institute of Surgical Research, University of Louisville, Louisville, KY, USA
S. Galandiuk (*) Division of Colon & Rectal Surgery, Hiram C Polk Jr., MD Department of Surgery, University of Louisville, Louisville, KY, USA e-mail: s0gala01@louisville.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025 M. Hoffman et al. (eds.), Major Complications of Female Pelvic Surgery,
https://doi.org/10.1007/978-3-031-66772-5_35
387
388
Palliative
Palliative
A. Macleod and S. Galandiuk
CRT*
CRT*
Groin
Groin
Dissection
Dissection
+/- Further
Chemotherapy
Chemotherapy
+/– Radiotherapy*
+/– Radiotherapy*
+/– Immunotherapy
+/– Immunotherapy
Disease
Disease
Metastatic
Metastatic
Salvage Surgery
Salvage Surgery
• APR
• APR
Local
Local
Recurrence/
Recurrence/
• ELAPE
• Exenteration
• ELAPE
• Exenteration
Progression
Progression
+/– Further
Node
Node
Inguinal
Inguinal
Recurrence
Recurrence
Surveillance
Surveillance
Disease
Disease
Metastatic
Metastatic
Chemo-radiotherapy (CRT)
Chemo-radiotherapy (CRT)
• 5-FU/Mitomycin or
• 5-FU/Mitomycin or
Loco-regional
Loco-regional
+
+
Anal Canal
Anal Canal
Cell Cancer
Cell Cancer
Squamous
Squamous
• Mitomycin/Capecitabine or
• 5-FU/Cisplatin
• Mitomycin/Capecitabine or
• 5-FU/Cisplatin
Disease
Disease
(any T,N stage)
(any T,N stage)
+
+
Radiotherapy
Radiotherapy
perineum and inguinal nodes)
perineum and inguinal nodes)
(Minimum 45Gy to pelvis, anus,
(Minimum 45Gy to pelvis, anus,
N+
N+
T0 poorly
T0 poorly
T2-4, or any
T2-4, or any
differentiated
differentiated
+
+
Peri-Anal
Peri-Anal
Squamous
Squamous
Consider re-excision first
Consider re-excision first
Cell Cancer
Cell Cancer
Inadequate Margins
Inadequate Margins
Local
Local
Excisionˆ
Excisionˆ
T1, NO Well
T1, NO Well
differentiated
differentiated
T1Nx supercial cancer completely excised at biopsy; *Additional CRT/radiotherapy
depending on prior dose/eld included. APR Abdominal-erineal resection, ELAPE
extra-levator abdominal-perineal resection
Adequate Margins
Adequate Margins
Suspected
Suspected
Anal Cancer
Anal Cancer
Anal adenocarcinoma and melanoma histology- use alternative treatment algorithm.
Fig. 35.1 Treatment algorithm following anal SCC diagnosis: Adapted from (3).
+
^Local excision: 1 cm margin recommended. Local excision also recommended in
35 Anal Cancer
Fig. 35.2 Perianal cancer without sphincter involvement
Complications ofRadical Surgery Performed forPersistentor Recurrent Disease
Major pelvic surgery is reserved for locally pro­gressive or recurrent disease, occurring in 10–30% of anal SCCcases [6, 7]. Patients who are HIV positive, those with advanced T or N stage, and incomplete CRT therapy have an increased risk of recurrence and requiring subse­quent radical surgery [8, 9]. A conventional APR or ELAPE (if there is an extension beyond the sphincters to the levators) are the most common salvage surgeries performed for anal SCC.The aims of salvage surgery are local disease control and prevention of distant recurrence. Positive resection margins are a reliable predictor of recurrence and poor survival; therefore, en-bloc resection of involved adjacent organs to achieve negative surgical margins may be required [10]. The reader is referred to Chap. 38 “Exenteration” for details specic to pelvic exenteration, which may be required with disease extending to involve
389
the bladder or in cases of severe radiation dam­age/radiation necrosis.
Due to the high dose of radiation utilized for the primary treatment of anal SCC, healing prob­lems are not uncommon in the postoperative period (see also Chap. 37, Pelvic Radiation Therapy). Added risk factors include malnutri­tion and the presence of cigarette smoking, which can also lead to impaired wound healing. The lat­ter has been linked to higher HPV16 viral levels [11]. Common complications include perineal wound infection/dehiscence, pelvic uid collec­tions/abscesses/organ space infections, perineal hernia, and small bowel obstruction. These will be discussed below.

Perineal Wound Infection/Dehiscence

Background
Impaired perineal wound healing is a major source of morbidity following pelvic surgery. APR for anal cancer generally follows the same technique principles as for rectal cancer (see Chap. 36); however, wider perineal margins or an extra-levator (ELAPE) approach may be required. A larger perineal wound in combination with higher doses of perineal radiation may result in an increased risk of wound infection and poor healing [12, 13]. The incidence ofwound dehis­cence or infection following primary closure var­ies but has been reported in 15–70% of cases following APR or ELAPE [7, 12, 14].
Prevention
The use of reconstructive muscle or myocutane­ous aps for perineal closure has led to reduced rates and severity of perineal wound complica­tions [15] (see also Chap. 41, Pelvic Reconstructive Procedures). A myocutaneous ap using rectus abdominis (VRAM), gluteal, or gracilis muscle are the most widely reported techniques (Fig. 35.3). Reconstructive aps aid with wound closure and contribute to reduced wound infections by lling the dead space within the pelvis. A 2016 meta-analysis of primary ver­sus ap closure included 10 studies and 566 patients. Eight studies used rectus abdominis
390
a b
A. Macleod and S. Galandiuk
Fig. 35.3 (a) Rectus muscle ap harvested to help ll a pelvis and (b) following abdominoperineal resection
aps and twoused gracilis aps. Overall major wound complications were higher in the primary closure groups [16]. In 98 patients undergoing salvage surgery for anal cancer, Baloch et al. reported signicantly higher perineal wound healing at 3 months following perineal recon­struction using a vertical rectus abdominis (VRAM) ap, versus primary closure or gluteal ap [17]. A small RCT comparing biologic mesh versus primary closure following ELAPE for rectal cancer found no difference in wound heal­ing at all time intervals measured [18]. Despite many retrospective studies and systematic
Recognition
Perineal wound dehiscence or poor healing pres­ents similarly to wound complications elsewhere, however, due to the location of the wound, it is at risk of being missed in the early postoperative period. Careful monitoring is crucial to identify early signs of complications such as inamma­tion, discharge, necrosis, or swelling, which may indicate a nonhealing wound or ap failure. Identication of the depth and extent of dehis­cence guides the appropriate management and will be dependent on the perineal reconstruction technique at primary surgery.
reviews, the heterogeneity of indication for sur­gery along with selection bias and confounding
Management
patient factors, has resulted in a lack of consen­sus regarding optimal perineal closure technique [13, 19].
Modiable risk factors associated with poor wound healing preoperatively should be addressed where possible, including preoperative smoking cessation, optimizing nutrition, and dia­betic control [13].
Acute
Full-thickness dehiscence with evisceration or ap loss are surgical emergencies and require an imme­diate return to the operating room for debridement and re-closure. Careful inspection of small bowel and mesentery for evidence of trauma should be performed prior to washout and re-closure [13].
35 Anal Cancer
Incomplete dehiscence with evidence of peri­neal infection should be managed with intrave­nous antibiotics, local exploration, and debridement of any nonviable tissue. CT scan evaluation for deeper pelvic collections or tracts should be performed and managed as per the sec­tion on pelvic uid collections below.
Chronic
A chronic nonhealing wound of >6months dura­tion is dened as a persistent perineal sinus. Recurrent or residual cancer should be considered in any persistent wound/sinus and an examination under anesthesia performed with biopsies of sus­picious areas along with exploring +/ deroong tracts. MRI is useful in assessing for recurrence or undrained uid collections. Denitive manage­ment is guided by the size of the wound and the involvement of surrounding structures. This can range from conservative local excision and debridement with the use of negative pressure dressings to extensive surgery involving coccy­gectomy or sacral body resection with muscle ap transposition. Negative pressure or vacuum­assisted closure (VAC) dressings are known to accelerate open wound healing via reduction of edema, mechanically drawing together wound edges, increasing local perfusion, and promoting the formation of granulation tissue [22, 23]. Although positionally more difcult to maintain a vacuum seal, these can be used for open perineal wounds with favorable outcomes. Alternative nonsurgical adjuncts, such as topical application of growth factors and mesenchymal stem cell treatments, are being explored in other chronic wounds, such as diabetic ulcers, and may in the future offer an alternative treatment option in per­ineal wound management [20, 21].

Pelvic Fluid Collections/Abscesses/ Organ Space Infections

Background
Pelvic uid collections following anorectal exci­sion often result from the accumulation of exuda­tive uid or hematoma in the pelvic dead space. More extensive excisions such as in ELAPE and
391
Fig. 35.4 Large infected presacral uid collection in a woman 10days following pelvic exenteration for compli­cations due to radiation therapy for anal squamous cell cancer
pelvic exenteration have increased dead space and are higher risk for organ space infection [13] (Fig. 35.4).
Prevention
Filling or excluding the empty pelvic space has been shown to improve perineal wound heal­ing and reduce both pelvic uid collection/ abscess formation and perineal hernia rates along with keeping small bowel out of the pelvis. Several techniques for pelvic exclusion have been described, including omentoplasty, mesh or ap reconstruction, prosthesis placement, and the use of terminal ileal mesentery to reconstruct the pelvic peritoneum [2426].
The use of an omental ap to obliterate the pelvic dead space has been reported in several case series and retrospective studies with contra­dictory results. The largest recent cohort study examining the benet of omentoplasty after APR/ELAPE for rectal cancer included a cohort of 477 patients (of which 96% received neoadju­vant CRT) who were found to have no benet from the omentoplasty + primary closure versus primary closure alone. Thirty-day nonhealing rates, chronic perineal wounds, and presacral abscess formation were similar [26]. These nd­ings were supported by a 2021 systematic review in which omentoplasty was not associated with risk of pelvic abscess formation, wound healing at 30 days, or chronic perineal sinus [27]. A 2022 systematic review of six different tech­niques for lling the empty pelvis following pel­vic exenteration found no consensus on the best
392
A. Macleod and S. Galandiuk
method of pelvic exclusion. Mesh reconstruc­tion and breast prosthesis placement were asso­ciated with the lowest rates of small bowel obstruction and abscess formation. Flap recon­struction had similar outcomes, although higher rates of perineal wound morbidity and re-opera­tion. Omentoplasty was associated with increased rates of wound infection and morbid­ity [28]. Some centers have trialed the use of obstetric balloons and silicone expanders, and while outcomes were promising in reported case series, there is insufcient evidence to compare to more traditional techniques.
Recognition
Patients develop pyrexia, leukocytosis often accompanied by abdominal pain, ileus, and a sys­temic inammatory response. Perineal wound discharge may increase or become purulent. Imaging with a CT scan can delineate a collec­tion and assess suitability for percutaneous drain­age. Imaging <5 days postoperative is likely to show a degree of free pelvic uid, which must be interpreted cautiously andin clinical context.
The nding of pelvic free uid in an unwell patient following APR/ELAPE should prompt consideration of inadvertent injury to surrounding structures such as small bowel, bladder, or ureters. Renal function and urinary output should be assessed, a discussion of recognition and manage­ment of urinary tract complications can be found in Chap. 17 “Injury/Repair of Pelvic Ureter”.
Management
Initial resuscitation and intravenous broad­spectrum antibiotics followed by percutaneous drainage is the primary management in most cases of pelvic abscess. CT-guided percutaneous drainage is the rst-line treatment for most abdominal-pelvic collections greater than 3 cm and is successful in >90% of patients, with low complication rates [29, 30]. Following drain placement, regular drain ushing ensures drain patency. Upsizing or re-positing of the drains may be required. Patients should undergo repeat imaging prior to drain removal to evaluate collec-
tion resolution along with microbial culture of abscess contents to rationalize antibiotic choice.
Patients without access to interventional radi­ology or signicant hemodynamic instability require a return to theatre for either laparoscopic or open surgical washout. Recurrent, multi­loculated, or complex intra-loop abscesses may not respond to conservative management and mayrequire surgical washout. In the case of very low-lying collections, these are sometimes most easily drained transperineally.
In the case of bilious drain output, communi­cation of abscess cavity with small bowel is likely, and the patient should be managed as for an entero-cutaneous stula. This is a rare compli­cation of APR/ELAPE, although may occur due to a missed, or failed repair of, inadvertent enter­otomy, particularly in patients with friable small bowel due to radiation enteritis. Detailed princi­ples of stula management are beyond the scope of this chapter; however, in brief, these include (i) control of infection, (ii) reduction of stula out­put, (iii) optimization of nutrition, and (iv) imag­ing with oral contrast and/or stulogram to assess anatomy prior to consideration of surgical repair. Most low output stula will heal without surgical intervention.

Perineal Hernia

Background
Perineal hernia is a late, and relatively underap­preciated, complication following APR/ ELAPE.There are little data regarding the inci­dence and outcomes of treatment, with much evi­dence reported from expert opinions and small case series with short follow-ups. High-dose radiation along with an extra-levator resection increases the risk of perineal hernia. Many small or minimally symptomatic hernias likely go undiagnosed; however, the overall incidence has been reported in studies between 12–26% [31,
32]. The incidence of this complication appears
to be increasing with the increase in minimally invasive surgical approach.
35 Anal Cancer
393
Prevention
Closure of a perineal defect with a reconstructive ap or mesh, and pelvic exclusion as described above for wound complication and pelvic abscess prevention, can also be used to reduce the fre­quency of perineal hernia. While not the primary aim of the study a prospective randomized con­trolled trial, comparing primary versus biologic mesh closure following ELAPE for rectal cancer found a signicantly lower 1-year perineal hernia rate in the biologic mesh closure patients (13 vs. 27%) [18]. Conversely, a large Dutch observa­tional study found the use of omentoplasty for pelvic space exclusion increased the rate of peri­neal hernia development [26]. Patients should be aware of modiable risk factors preoperatively to reduce the risk of perineal hernia, including weight loss, careful postoperative wound care, and avoidance of strenuous daily activities postoperatively.
Recognition
The diagnosis of a perineal hernia is primarily clinical, with patients reporting a bulge or mass, often positional and associated with pain or dis­comfort. Complications associated with perineal hernia include skin erosion, urinary or sexual dysfunction, and bowel obstruction. CT or MRI imaging may be useful in supporting diagnosis, however, hernias that present on standing or straining may not be detected on imaging.
there was no signicant risk difference identied between any repair techniques. Synthetic mesh had the lowest recurrence rate but the highest postoperative morbidity [33].

Small Bowel Obstruction

Background
There is an increased risk of small bowel obstruc­tion (SBO) following surgery due to pre- operative high-dose chemoradiation in anal SCC.The ter­minal ileum is at particular risk of radiation enteritis (see section “Complications of Therapy
(Chemoradiation)” later in this chapter) and is
often the site of SBO (Fig. 35.5). Other causes of obstruction include surgical adhesions or small bowel adherent in the pelvis with associated radiation- induced brosis.
Prevention
Pelvic exclusion techniques, as described above, aim to keep small bowel out of the pelvis and reduce the risk of SBO, along with the risk of additional injury associated with further radia­tion. Closure of the pelvic peritoneum using the distal ileal mesentery was rst described in
Management
Given the relative rarity of this complication, there is a lack of consensus on the optimal surgi­cal approach (perineal vs. abdominal) or tech­nique (primary closure, insertion of mesh, reconstructive ap, or combination) for repair. A recent meta-analysis of 29 studies included 325 patients undergoing 347 perineal hernia repairs and found an overall recurrence rate of 22% with no signicant difference between the abdominal versus perineal approach. A combined approach was reported in ve studies, and results appear to suggest a lower rate of recurrence; however, cur­rent evidence is not sufcient to conrm this. Mesh repairs have largely replaced primary repair in recent years; however, at meta-analysis,
Fig. 35.5 Coronal CT scan showing severely narrowed small bowel (white arrows) due to radiation enteritis resulting in refractory small bowel obstruction